Stryker, a major US medical equipment company, said a cyberattack disrupted its global networks Wednesday. "We have no indication of ransomware or malware and believe the incident is contained. Our teams are working rapidly to understand the impact of the attack on our systems," Stryker said in a statement on its website. The logo of Handala, a hacking group linked to Iran, has appeared on company login pages, The Wall Street Journal reported. Stryker's statement said the cyberattack hit its Microsoft programs. Emails seeking additional information were not immediately answered. Stryker is based in Portage, Michigan, and makes a variety of medical products, from artificial joints to hospital beds. It had revenue of more than USD 25 billion in 2025. The company says it has 56,000 employees around the world.
The pharmaceuticals department has invited stakeholder comments on proposed changes to the list of 350-plus medical devices exempt from GTE rules, with submissions open until February
US tariff cut lifts Indian medical devices; pharma steady, nutraceuticals seek clarity
Ahead of Budget 2026-27, healthcare, medtech and pharma firms seek tax relief, higher R&D incentives and stronger support for preventive care and domestic manufacturing
The regulator told states not to demand USFDA or EU approvals in tenders after complaints that Indian-made devices were being sidelined
Pune-based Biorad Medisys is developing an implantable vagus nerve stimulation device that aims to improve insulin balance, regulate hunger, and support obesity care without drugs or chemical compound
The transaction underscores Inviga's commitment to supporting world-class, AI-driven diagnostic solutions conceived and built in India for global scale
Draft guidelines aim to align India's medtech software framework with global practices; industry seeks more clarity on AI/ML evaluation and algorithm change management
The ministry has issued a draft notification proposing an amendment to add qualifications for inspectors and government analysts under Rule 18 of the Medical Device Rules (MDR), 2017
The NPPA has extended the ceiling price for knee implants till November 2025 while considering industry pleas for removal, citing rising costs and supply chain issues
Industry body Aimed says proposed balanced reforms could help reduce healthcare costs for consumers
Industry bodies asked the govt for a three-month transition period, use of old packaging, and a simpler GST refund mechanism to avoid supply chain disruptions in healthcare
GST rationalisation lowers costs for medical consumables and high-end therapies, benefiting patients. However, pharma companies, particularly in biologics, may face margin pressure due to ITC loss
GST reduction on medical devices, diagnostic kits, and reagents is a welcome move, but leading diagnostic players believe test prices will remain largely unaffected due to minimal changes
GST Council meet outcome: GST on various medical apparatus and devices used for medical, surgical, dental or veterinary usage has been reduced to 5% from 12%
Imports should be restricted to original manufacturers or certified partners, while devices that are too old or have exceeded usage thresholds should be barred
AIMED said GST changes could hurt domestic medtech competitiveness and tilt the market towards imports, urging balanced tax slabs, refund reforms, and a higher Health Cess
A high-level inter-departmental committee has begun discussions on regulating refurbished medical devices, balancing patient safety concerns with affordable healthcare access
Medical device companies raise issues with the DoP over UDMPMD norms related to disclosure of training expenses and restrictions on overseas training approvals
Medical device makers can now outsource sterilisation through third-party agreements without loan licences if the facility holds a valid sterilisation licence